Antiphospholipid syndrome and palindromic rheumatism: A new possible association

Tatiana Reitblat, Irena Litinsky, Dan Caspi, Ori Elkayam

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Objective: The aim of this study was to report six patients with palindromic rheumatism (PR) in whom signs, symptoms, and/or serologic evidence of antiphospholipid syndrome (APS) developed. Methods: The medical histories of the patients were reviewed with special emphasis on age, gender, duration of PR, and lapse of time until antiphospholipid antibodies were detected or APS was diagnosed. Three representative cases are described. Results: Two patients were women and four were men. Their mean age was 49.3 years (range 36-80), and the mean duration of PR was 5.5 years (range 3-8). In all patients, raised titers of antiphospholipid antibodies were found on two or more occasions. Two patients developed clinical pictures compatible with APS, two showed symptoms which may be attributable for APS, and raised titers of antiphospholipid antibodies were found in only two. Conclusion: It seems that the appearance of these two uncommon conditions together is more than coincidental and may point to a previously unreported clinical association.

Original languageEnglish
Pages (from-to)595-598
Number of pages4
JournalRheumatology International
Issue number8
StatePublished - 1 Oct 2005
Externally publishedYes


  • Anticardiolipin antibody
  • Antiphospholipid syndrome
  • Palindromic rheumatism

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Antiphospholipid syndrome and palindromic rheumatism: A new possible association'. Together they form a unique fingerprint.

Cite this